Upper Gastrointestinal Endoscopy (Diagnostic and Therapeutic)
JH · Effective Oct 1, 2015
6 active Medicare policies list 43192, and 8 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2025
8 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 43192 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2026 | Covered |
| Device Therapies for Gastroesophageal Reflux Disease (GERD) | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 43192 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2026 | Covered |
| Device Therapies for Gastroesophageal Reflux Disease (GERD) | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 43192 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2026 | Covered |
| Device Therapies for Gastroesophageal Reflux Disease (GERD) | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 43192 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2026 | Covered |
| Device Therapies for Gastroesophageal Reflux Disease (GERD) | Jan 1, 2026 | Covered |